Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMBINE 1: Weekly IcoSema versus weekly insulin icodec in type 2 diabetes inadequately controlled on daily basal insulin
jRCT2031220146Completed
- Sponsor
- Novo Nordisk
- Start
- Jun 2022
- Modality
- Peptides
01
Overview
Randomised trial in type 2 diabetes mellitus (T2DM) comparing Once-weekly IcoSema with Once-weekly insulin icodec (2 arms). Primary endpoint: Change in HbA1c. Started Jun 2022; status: completed.
02
Drugs
icosemainsulin icodec
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT2031220146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031220146.